Shuanglu Pharmaceutical: The long-acting and short-acting follicle-stimulating hormone developed by the company is currently in the second and third clinical phases, and it is expected that registration applications will be submitted in one or two years.

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

002038 300713 Beijing Sl Pharmaceutical Shenzhenrease Technology Restructuring, Recapitalisation Pharmaceutical Marriage

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Shuanglu Pharmaceutical: The long-acting and short-acting follicle-stimulating hormone developed by the company is currently in the second and third clinical phases, and it is expected that registration applications will be submitted in one or two years.